Paper41454503
Studies on Secondary Metabolites of Streptomyces gossypiisoli TRM 44567 under the Guidance of OSMAC Strategy.
Chen YH and 6 others. Pol J Microbiol, 2025. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Studies on Secondary Metabolites of Streptomyces gossypiisoli TRM 44567 under the Guidance of OSMAC Strategy. Papers, record 41454503. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41454503
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Studies on Secondary Metabolites of Streptomyces gossypiisoli TRM 44567 under the Guidance of OSMAC Strategy.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Streptomyces | Major topic |
| Secondary Metabolism | Major topic |
| Multigene Family | |
| Pseudomonas aeruginosa | |
| Anti-Bacterial Agents | |
| Genome, Bacterial | |
| Biological Products | |
| Fermentation |
Source PubMed
References32
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 36979037 | Genome-Based Analysis of the Potential Bioactivity of the Terrestrial Streptomyces vinaceusdrappus Strain AC-40. | Biology (Basel) | 2023 | https://conductscience.org/library/papers/36979037 | PubMed |
| 2 | 10513843 | Cineromycins, gamma-butyrolactones and ansamycins by analysis of the secondary metabolite pattern created by a single strain of Streptomyces. | J Antibiot (Tokyo) | 1999 | https://conductscience.org/library/papers/10513843 | PubMed |
| 3 | 26860735 | Antibacterial and antifungal activities of 2,3-pyrrolidinedione derivatives against oral pathogens. | Bioorg Med Chem Lett | 2016 | https://conductscience.org/library/papers/26860735 | PubMed |
| 4 | 21778983 | Tirandamycin biosynthesis is mediated by co-dependent oxidative enzymes. | Nat Chem | 2011 | https://conductscience.org/library/papers/21778983 | PubMed |
| 5 | 39397793 | Aplospojaveedins A-C, unusual sulfur-containing alkaloids produced by the endophytic fungus Aplosporella javeedii using OSMAC strategy. | Front Microbiol | 2024 | https://conductscience.org/library/papers/39397793 | PubMed |
| 6 | 19883065 | Isolation and characterization of tirandamycins from a marine-derived Streptomyces sp. | J Nat Prod | 2009 | https://conductscience.org/library/papers/19883065 | PubMed |
| 7 | 12324995 | Big effects from small changes: possible ways to explore nature's chemical diversity. | Chembiochem | 2002 | https://conductscience.org/library/papers/12324995 | PubMed |
| 8 | 21329667 | Cloning and characterization of the biosynthetic gene cluster of the bacterial RNA polymerase inhibitor tirandamycin from marine-derived Streptomyces sp. SCSIO1666. | Biochem Biophys Res Commun | 2011 | https://conductscience.org/library/papers/21329667 | PubMed |
| 9 | 38377824 | OSMAC Strategy: A promising way to explore microbial cyclic peptides. | Eur J Med Chem | 2024 | https://conductscience.org/library/papers/38377824 | PubMed |
| 10 | 33269996 | Streptomyces gossypiisoli sp. nov., isolated from cotton soil in Xinjiang, PR China. | Int J Syst Evol Microbiol | 2021 | https://conductscience.org/library/papers/33269996 | PubMed |
| 11 | 21405052 | Tirandamycins from Streptomyces sp. 17944 inhibiting the parasite Brugia malayi asparagine tRNA synthetase. | Org Lett | 2011 | https://conductscience.org/library/papers/21405052 | PubMed |
| 12 | 18274517 | Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances. | Nat Protoc | 2008 | https://conductscience.org/library/papers/18274517 | PubMed |
| 13 | 23715040 | Medium optimization of Streptomyces sp. 17944 for tirandamycin B production and isolation and structural elucidation of tirandamycins H, I and J. | J Antibiot (Tokyo) | 2014 | https://conductscience.org/library/papers/23715040 | PubMed |
| 14 | 31064143 | Biosynthesis of Polyketides in Streptomyces. | Microorganisms | 2019 | https://conductscience.org/library/papers/31064143 | PubMed |
| 15 | 23428572 | Natural products: a continuing source of novel drug leads. | Biochim Biophys Acta | 2013 | https://conductscience.org/library/papers/23428572 | PubMed |
| 16 | 791108 | Tirandamycin, an inhibitor of bacterial ribonucleic acid polymerase. | Antimicrob Agents Chemother | 1976 | https://conductscience.org/library/papers/791108 | PubMed |
| 17 | 29662222 | Function and functional redundancy in microbial systems. | Nat Ecol Evol | 2018 | https://conductscience.org/library/papers/29662222 | PubMed |
| 18 | 35485872 | Recent methods for discovering novel bioactive metabolites, specifically antimicrobial agents, from marine-associated micro-organisms. | Lett Appl Microbiol | 2022 | https://conductscience.org/library/papers/35485872 | PubMed |
| 19 | 25294726 | Streptomyces vulcanius sp. nov., a novel actinomycete isolated from volcanic sediment. | Antonie Van Leeuwenhoek | 2015 | https://conductscience.org/library/papers/25294726 | PubMed |
| 20 | 31187317 | Rare actinobacteria: a potential source of bioactive polyketides and peptides. | World J Microbiol Biotechnol | 2019 | https://conductscience.org/library/papers/31187317 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41454503
GET https://conductscience.org/api/papers/v1/41454503/references?page=2